The study of pathological mechanisms at the cellular and molecular levels has been the focus of my academic and professional career since obtaining my Biology degree from the Universitat Autònoma de Barcelona. My international research trajectory has allowed me to explore these mechanisms while applying cutting-edge technologies.

During my PhD at the Institute of Molecular Pathology (IMP) in Vienna, under the supervision of Dr. Carrie Cowan, I specialized in live-cell imaging and 4D digital image analysis. To expand my expertise in translational biology, I joined Prof. Bass Hassan’s lab at the Sir William Dunn School of Pathology, University of Oxford, where I worked as a postdoctoral researcher. There, I led the development of an image-based clinical trial evaluating the effects of a novel drug on Ewing Sarcoma, a rare bone cancer in children and young adults. This experience significantly deepened my knowledge of cancer biology and clinical trial design.

Following my maternity leave, I joined the Instituto de Investigación Sanitaria del Hospital Clínico Universitario de Valencia (INCLIVA), where I engaged in a broad range of translational research strategies, including biomarker discovery, gene therapy assays, patient stratification, and treatment response prediction. These approaches integrated anatomical, genomic, imaging, and computational data. In collaboration with the low-prevalence tumor research group at CIBERONC, we contributed to impactful studies, such as the development of tools for predicting disease progression and therapeutic outcomes in rare and biologically heterogeneous conditions.

My research continues to focus on low-prevalence diseases with high biological heterogeneity, including both neoplastic and non-neoplastic disorders characterized by complex molecular dysfunctions. Employing multi-omics technologies, histological image analysis, high-resolution microscopy, and artificial intelligence, I aim to develop integrative models for disease characterization, patient stratification, and therapeutic prediction, with a strong translational orientation aligned with precision medicine.

Currently, I am a full-time professor in the Department of Biomedical Sciences at Universidad CEU Cardenal Herrera and a member of the MRT (Musculoskeletal Regenerative Therapies) research group. This group investigates injuries to the musculoskeletal system—including tendon and muscle lesions—with the goal of developing regenerative or reconstructive therapies that preserve the integrity and mobility of the tendon-muscle unit. Within this framework, I apply artificial intelligence to digital image analysis to enhance molecular characterization and therapeutic strategies, integrating computational innovation with translational biomedical research.